Skip to content

    Navigation breadcrumbs

  1. Home
  2. Veterinary topics and resources
  3. All resources
  4. Shamonda virus

Library and information services

Access to electronic and print resources focused on veterinary science and animal health, plus services to support your study and keep up to date with clinical research.

Awards

Our awards celebrate achievements and build knowledge that contributes to evidence-based veterinary medicine.

History

Explore a unique collection of books, archives, artworks and artefacts that chronicle the development of veterinary science and the roles veterinary professionals have played in society over centuries.

    Navigation breadcrumbs

  1. Home
  2. Veterinary topics and resources
  3. All resources
  4. Shamonda virus
Evidence collection5 November 2026

Shamonda virus

This evidence collection draws together research on Shamonda virus

Published 5 November 2026

Shamonda virus (SHAV) has been detected in cattle at two dairy farms in Great Britain (one located in Powys, Wales and one in Shropshire, England).   Shamonda virus detected in livestock in Great Britain for first time – GOV.UK

The purpose of this evidence collection is to provide links to resources from reliable sources to help you recognise and investigate animals that might be affected by Shamonda virus.

Reports and references relating to recent cases in Europe are also included. However, as this is a rapidly evolving situation, it should be noted that some of the papers referenced are currently reports (Eurosurveillance) or in pre-print (bioRxiv} and have not been through peer review.

What is Shamonda virus?

Shamonda virus is an orthobunyavirus of the Simbu serogroup and is closely related to Schmallenberg virus (SBV). SHAV is believed to be transmitted by Culicoides biting midges, the same vector responsible for transmission of SBV and bluetongue virus.

Shamonda virus was first detected in Nigeria in the mid-1960s and has since been reported sporadically in cattle in West, East and southern Africa and in Japan. Since summer 2026, SHAV has been detected in in several European countries, with cases reported in cattle, sheep, goats, horses and an alpaca.

Symptoms and Clinical signs

Acute disease has been reported in adult cattle which develop the following clinical signs

Multiple animals may be affected over a 14-21 day period. Pregnant cows are at risk of stillbirths and calf malformations, these may include arthrogryposis, torticollis, scoliosis and brain deformities such as hydranencephaly, porencephaly, and cerebellar hypoplasia.

 No acute disease has been observed in sheep or goats to date, although congenital abnormalities have been reported in lambs.

SHAV has been detected in horses including cases identified in Germany and Switzerland. This is of particular significance because these horses have shown neurological signs including seizure-like episodes as well as fever and ataxia.

Investigation and reporting of disease

While Shamonda virus is not a notifiable disease the clinical signs may overlap with a number of other diseases, including bluetongue which is notifiable.

APHA are recommending that if you see cattle, sheep or goats in England and Wales with compatible signs, contact your local surveillance pathology centre to discuss investigation. APHA is providing free-of-charge SBV and SHAV testing from October 2026 to May 2027 on calves, lambs and kids with arthrogryposis or other congenital musculoskeletal abnormalities. Submit a fresh brain sample (brainstem preferred) and request testing for SBV and SHAV on the submission form.

Concerns have been raised that some of the neurological signs described in horses may resemble those seen in notifiable equine diseases, including West Nile fever, potentially complicating the investigation of horses presenting with neurological disease.

Outbreaks in Europe

There have been a number of reports of affected animals in Europe which may provide further evidence to help our understanding of the disease, in terms of clinical signs, epidemiology and public health impact.

Epidemiology

Public health

APHA reports that there is no evidence that SHAV poses a food safety risk. UKHSA has undertaken a rapid risk assessment, which considers SHAV to present a very low risk to the general population in the UK at the current time. A full assessment is being undertaken by the Human Animal Infection and Risk Surveillance (HAIRS) group.

However, there has been a report of a single human infection in France, in a patient with a severely weakened immune system

About evidence collections

Evidence collections bring together collections of published papers on topics of interest and importance to the veterinary professions. Papers are chosen for relevance and accessibility, with the full text of articles either being available through the RCVS Knowledge library, on open access or from other publications to which a significant number of veterinary professionals are likely to have access. This means that there may be relevant evidence that is not included.

If you would like assistance in searching for further evidence on this topic you may find the following helpful EBVM Toolkit 2: Finding the best available evidence.

If you would like to suggest a paper for inclusion in one of our published evidence collections, or a topic for a future collection, please email library@rcvsknowledge.org

Next steps

Receive the latest updates by email

Sign-up to receive bi-monthly updates on all things new in evidence-based veterinary medicine.

Claim CPD credit for your reading

Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process